Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico

In June 2020, Zydus Cadila had received approval from Mexico's
regulatory authority Cofepris to test one of its lead research
candidate Desidustat in the management of COVID-19.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/articleshow/80444749.cms

Comments

Popular posts from this blog

Pharos of Chaos

NIAB Pharma JRF Job Opening – Application Details

Crimson Toastmasters Club